Current and emerging systemic treatments targeting the neural system for chronic pruritus

Expert Opinion on Pharmacotherapy
Rachel Shireen Golpanian, Gil Yosipovitch

Abstract

Pruritus is a debilitating symptom that significantly affects the quality of life of patients who suffer from it. Many current and emerging systemic treatments targeting the neural system have been successful in treating itch of various underlying etiologies. A complete search of the PUBMED and Google Scholar databases was completed and literature pertinent to current and emerging systemic anti-pruritic drugs which target the neural system was compiled. The purpose of this review is to give the reader with an overview of the current and emerging systemic therapeutic options which target the neural system for chronic pruritus. The authors then provide the reader with their expert perspectives on the future of these therapies. Exciting new anti-pruritic therapies targeting the neural system which show promise include NK-1 inhibitors, opioid receptor modulators, and drugs targeting specific itch receptors such as Mrgpr, Nav1.7, and PAR2, as well as selective GABA modulators. Future studies should be conducted in order to fully understand these exciting therapeutic options.

References

Oct 1, 1996·Journal of Pain and Symptom Management·E DuntemanK S Filos
Nov 9, 2000·The British Journal of Dermatology·G YosipovitchC L Goh
Dec 12, 2001·British Journal of Haematology·F Diehn, A Tefferi
Mar 5, 2003·Journal of Pain and Symptom Management·Mellar P DavisSandy Taylor
Dec 5, 2003·Journal of Pain and Symptom Management·Zbigniew ZyliczMassimo Costantini
Dec 23, 2003·The American Journal of Gastroenterology·Jeff BrowningMarlyn J Mayo
Apr 22, 2004·The British Journal of Dermatology·S M WinhovenW W Bottomley
May 22, 2004·Journal of the American Academy of Dermatology·Jennifer L Hundley, Gil Yosipovitch
Nov 24, 2004·Burns : Journal of the International Society for Burn Injuries·J E Mendham
Nov 25, 2004·The Annals of Pharmacotherapy·Alison M Massaro, Kristi L Lenz
Dec 3, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ali Ihsan GunalHuseyin Celiker
Oct 28, 2005·Journal of the American Society of Nephrology : JASN·Björn WikströmYuji Ueno
Dec 7, 2005·Proceedings of the National Academy of Sciences of the United States of America·G D IannettiI Tracey
Dec 21, 2005·Archives of Dermatology·P D Yesudian, N J E Wilson
Feb 21, 2006·Journal of the American Academy of Dermatology·Aerlyn G Dawn, Gil Yosipovitch
Mar 31, 2006·Thyroid : Official Journal of the American Thyroid Association·S DvorákováB Bendlová
Feb 28, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marlyn J MayoA John Rush
Jun 26, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·T MoriH Honjo
Oct 26, 2007·Journal of the European Academy of Dermatology and Venereology : JEADV·M P LoosemoreJ D Bernhard
Apr 22, 2008·Journal of the European Academy of Dermatology and Venereology : JEADV·B AmatyaK Nordlind
Aug 21, 2008·British Journal of Anaesthesia·M J SheenS-T Huang
May 21, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·F MalekzadS Nasiri
Oct 3, 2009·The New England Journal of Medicine·Arnaud Duval, Louis Dubertret
Nov 21, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hiroo KumagaiHiromichi Suzuki
Apr 27, 2010·Dermatologic Therapy·Gulsum GencoglanKamer Gunduz
Jul 16, 2010·The Journal of Dermatology·Sadik YilmazVahide Baysal Akkaya
Jan 12, 2011·The British Journal of Dermatology·H L Tey, G Yosipovitch
May 10, 2012·The Journal of Dermatology·Jung-Min ParkByung-Soo Kim
Jul 24, 2012·Journal of Pain and Symptom Management·Linda ShavitItzchak Slotki
Aug 8, 2012·American Journal of Nephrology·Hiroo KumagaiHiromichi Suzuki
Sep 14, 2012·International Journal of Nephrology·Mansor ShakibaHassan Sharifi
Sep 28, 2012·Journal of Clinical Pharmacy and Therapeutics·M MazzaS Mazza
Dec 19, 2012·Clinics in Dermatology·Hong Liang TeyGil Yosipovitch
Feb 22, 2013·The Australasian Journal of Dermatology·Angeline YongHong Liang Tey

❮ Previous
Next ❯

Citations

Mar 9, 2021·Frontiers in Medicine·Aylin RuppensteinUlrike Raap
Nov 17, 2020·Expert Opinion on Pharmacotherapy·Zoe M Lipman, Gil Yosipovitch
Jun 2, 2021·The Medical Clinics of North America·Zoe M LipmanGil Yosipovitch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Dermatologic Clinics
Matthew W McEwenTejesh Patel
Expert Opinion on Pharmacotherapy
Carolyn StullGil Yosipovitch
Seminars in Cutaneous Medicine and Surgery
Sarina B Elmariah, Ethan A Lerner
Expert Opinion on Emerging Drugs
Kayla FourzaliGil Yosipovitch
Journal of Rehabilitation Medicine
Emilie Fowler, Gil Yosipovitch
© 2022 Meta ULC. All rights reserved